By Robin Respaut and Maggie Fick SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

In her late 20s, Johnna Byrd was stuck. She was living in Las Vegas, but didn’t have much desire to do anything other than ...

Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...

Thousands taking Mounjaro privately are inundating GP surgeries - clogging phone lines, exacerbating the 8am scramble for ...

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...

An injectable weight-loss treatment is now available through primary care across the UK - and general practices across ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Women on Mounjaro may miss signs of pancreatitis. Learn the symptoms, risks, and what UK health authorities are doing to ...

Around a fifth of users report not losing the expected amounts of weight on Mounjaro, and doctors have some answers ...